What's on the web on your pursuit, hobbies, interests and worries

ClinicalTrials news

How Patients Are Changing Clinical Trials


Forbes - May 17, 2017
By Emily Gurnon, Next Avenue Contributor. In September, the Food and Drug Administration (FDA) approved a controversial drug to treat Duchenne muscular dystrophy, a rare but deadly disease that affects boys. That was a reversal from six months earlier, ...
 

India to roll out new drug policy, devise rules for clinical trials, say officials


Firstpost - May 20, 2017
India is expected to roll out a new drug policy and devise rules for clinical trials that may bring new projects to the country, a top Indian official has said. A team of Indian officials led by G N Singh, Drug Controller General of India, said a set ...
 

Researcher with stage 4 cancer launches site to help others navigate clinical trials


STAT - May 17, 2017
mong patients with colon cancer, researcher Tom Marsilje 1 has made a name for himself by helping others learn about new clinical trials. He has scoured the database ClinicalTrials.gov, circulated a weekly spreadsheet, and served as a clearinghouse for ...
 

Clinical Trials - premium items on eBay

USED (GD) A Clinical Trials Manual From The Duke Clinical Research Institute: Le


 

NEW Textbook of Clinical Trials


 

Fundamentals of Clinical Trials


 

>> Go to all great Clinical Trials deals on eBay


Clinical Trials books


Hurst's the Heart, 14th Edition: Two Volume Set


by: Valentin Fuster, Robert A. Harrington, Jagat Narula, Zubin J. Eapen

THE BOOK THAT EVERY CARDIOLOGIST SHOULD OWN -- THE BEST EDITION YET!

  • ALL CHAPTERS HAVE BEEN COMPLETELY REWRITTEN
  • MANY NEW EXPERT AUTHORS
  • MOST REFERENCES ARE LESS THAN FIVE YEARS OLD
  • NEW REDRAWN FIGURES REFLECT THE LATEST INFORMATION
  • COVERAGE OF THE MOST RECENT CLINICAL TRIALS, PRACTICE GUIDELINES, AND EVIDENCE-BASED MEDICINE

5 STAR DOODY'S REVIEW!
.
>> More info on Amazon


Fundamentals of Clinical Trials


by: Lawrence M. Friedman, Curt D. Furberg, David L. DeMets, David M. Reboussin, Christopher B. Granger

This is the fifth edition of a very successful textbook on clinical trials methodology, written by recognized leaders who have long and extensive experience in all areas of clinical trials. The three authors of the first four editions have been joined by two others who add great expertise. A chapter on regulatory issues has been included and the chapter on data monitoring has been split into two and expanded. Many contemporary clinical trial examples have been added. There is much new material on adverse events, adherence, issues in analysis, electronic data, data sharing and international trials.
>> More info on Amazon


Drugs: From Discovery to Approval


by: Rick Ng

The third edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. 

Concise and easy to read, Drugs: From Discovery to Approval, Third Edition quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs.
>> More info on Amazon


Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3E


by: Gordon Guyatt

The leading guide to the principles and clinicalapplications of evidence-based medicine--updated with new examples and new chapters

A Doody's Core Title for 2015!